Dissociation of cerebrospinal fluid amyloid- and tau levels in patients with prolonged posttraumatic disorders of consciousness

被引:9
|
作者
Bagnato, Sergio [1 ,2 ]
Andriolo, Maria [3 ]
Boccagni, Cristina [1 ,2 ]
Sant'Angelo, Antonino [1 ,2 ]
D'Ippolito, Maria Enza [3 ]
Galardi, Giuseppe [1 ,2 ]
机构
[1] Giuseppe Giglio Fdn, Unit Neurophysiol, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[2] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[3] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy
关键词
Amyloid beta; traumatic brain injury; total tau; phosphorylated tau; vegetative state; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DEMENTIA; RISK; BIOMARKERS; INFLAMMATION; CONCORDANCE; POPULATION; PATHOLOGY;
D O I
10.1080/02699052.2018.1479042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease (AD). Although the mechanisms that lead to AD after a TBI are unclear, we hypothesize that changes in amyloid- (A) metabolism and abnormal tau phosphorylation are reasonable candidates.Objective: To investigate A and tau dynamics in the chronic phase of TBI.Methods: We evaluated A(1-42), total tau (t-tau), and phosphorylated tau (p-tau) levels in the cerebrospinal fluid (CSF) of 15 patients who developed a prolonged disorder of consciousness after a severe TBI (mean time from TBI 271.6176.5days).Results: Reduced A(1-42) levels (median 258pg/ml, range 90-833.6) were observed in 14/15 patients (93.3%) with severe post-TBI disorders of consciousness. These CSF analysis data did not correlate with time since TBI or with the patients' level of consciousness as determined by the Coma Recovery Scale Revised. Normal t-tau levels (median 95.2 pg/ml, range 52-256.9) were found in all patients. Normal p-tau levels (median 22.2pg/ml, range 14-72) were observed in 14/15 patients, with just a single patient having a slightly increased p-tau level.Conclusion: The present findings show that A and tau are differently affected in the chronic phase of severe TBI.
引用
收藏
页码:1056 / 1060
页数:5
相关论文
共 50 条
  • [1] Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia
    Chen, Dong-Wan
    Wang, Jun
    Zhang, Li-Li
    Wang, Yan-Jiang
    Gao, Chang-Yue
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (02) : 645 - 651
  • [2] Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia
    Skillback, Tobias
    Farahmand, Bahman Y.
    Rosen, Christoffer
    Mattsson, Niklas
    Nagga, Katarina
    Kilander, Lena
    Religa, Dorota
    Wimo, Anders
    Winblad, Bengt
    Schott, Jonathan M.
    Blennow, Kaj
    Eriksdotter, Maria
    Zetterberg, Henrik
    BRAIN, 2015, 138 : 2716 - 2731
  • [3] Dynamics of Amyloid-β and Total Tau in Cerebrospinal Fluid and Plasma of Patients on Hemodialysis
    Gorji, Hassan
    Wang, Lin-Chun
    Thwin, Ohnmar
    Chao, Joshua Emmanuel
    Debure, Ludovic
    Grobe, Nadja
    Wang Xin
    Zhang Hanjie
    Thijssen, Stephan
    Wisniewski, Thomas
    Kotanko, Peter
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [4] Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
    Voyle, Nicola
    Patel, Hamel
    Folarin, Amos
    Newhouse, Stephen
    Johnston, Caroline
    Visser, Pieter Jelle
    Dobson, Richard J. B.
    Kiddle, Steven J.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (04) : 1417 - 1427
  • [5] Amyloid-β peptide levels in serum and cerebrospinal fluid of multiple sclerosis patients
    Coyle, PK
    Mehta, PD
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 489 - 489
  • [6] Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
    Maia, Luis F.
    Kaeser, Stephan A.
    Reichwald, Julia
    Hruscha, Michael
    Martus, Peter
    Staufenbiel, Matthias
    Jucker, Mathias
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (194)
  • [7] Glycemia and Levels of Cerebrospinal Fluid Amyloid and Tau in Patients Attending a Memory Clinic
    Exalto, Lieza G.
    van der Flier, Wiesje M.
    Scheltens, Phillip
    Biessels, Geert Jan
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 (07) : 1318 - 1321
  • [8] Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus
    Kawamura, Kaito
    Miyajima, Masakazu
    Nakajima, Madoka
    Kanai, Mitsuyasu
    Motoi, Yumiko
    Nojiri, Shuko
    Akiba, Chihiro
    Ogino, Ikuko
    Xu, Hanbing
    Kamohara, Chihiro
    Yamada, Shinya
    Karagiozov, Kostadin
    Ikeuchi, Takeshi
    Kondo, Akihide
    Arai, Hajime
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (01) : 179 - 190
  • [9] NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer's Disease
    Garcia-Escobar, Greta
    Puig-Pijoan, Albert
    Puente-Periz, Victor
    Fernandez-Lebrero, Aida
    Maria Manero, Rosa
    Navalpotro-Gomez, Irene
    Suarez-Calvet, Marc
    Grau-Rivera, Oriol
    Contador-Munana, Jose
    Cascales-Lahoz, Diego
    Duran-Jorda, Xavier
    Boltes, Nuncia
    Claustre Pont-Sunyer, Maria
    Ortiz-Gil, Jordi
    Carrillo-Molina, Sara
    Dolores Lopez-Villegas, Maria
    Teresa Abellan-Vidal, Maria
    Isabel Martinez-Casamitjana, Maria
    Jose Hernandez-Sanchez, Juan
    Padros-Fluvia, Anna
    Pena-Casanova, Jordi
    Sanchez-Benavides, Gonzalo
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (04) : 1303 - 1321
  • [10] Effect of human cerebrospinal fluid sampling frequency on amyloid-β levels
    Li, Jinhe
    Llano, Daniel A.
    Ellis, Teresa
    LeBlond, David
    Bhathena, Anahita
    Jhee, Stanford S.
    Ereshefsky, Larry
    Lenz, Robert
    Waring, Jeffrey F.
    ALZHEIMERS & DEMENTIA, 2012, 8 (04) : 295 - 303